- Home
- VIST vs ACLX Comparison
VIST vs ACLX Comparison
Compare VIST & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIST
- ACLX
- Stock Information
- Founded
- VIST 2017
- ACLX 2015
- Country
- VIST Mexico
- ACLX United States
- Employees
- VIST N/A
- ACLX N/A
- Industry
- VIST Oil & Gas Production
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- VIST Energy
- ACLX Health Care
- Exchange
- VIST Nasdaq
- ACLX Nasdaq
- Market Cap
- VIST 5.1B
- ACLX 3.4B
- IPO Year
- VIST 2019
- ACLX 2022
- Fundamental
- Price
- VIST $53.65
- ACLX $69.13
- Analyst Decision
- VIST Buy
- ACLX Strong Buy
- Analyst Count
- VIST 5
- ACLX 14
- Target Price
- VIST $61.40
- ACLX $107.67
- AVG Volume (30 Days)
- VIST 899.4K
- ACLX 726.9K
- Earning Date
- VIST 02-26-2025
- ACLX 02-26-2025
- Dividend Yield
- VIST N/A
- ACLX N/A
- EPS Growth
- VIST 44.42
- ACLX N/A
- EPS
- VIST 5.18
- ACLX N/A
- Revenue
- VIST $1,485,646,000.00
- ACLX $155,818,000.00
- Revenue This Year
- VIST $41.77
- ACLX $12.58
- Revenue Next Year
- VIST $29.69
- ACLX N/A
- P/E Ratio
- VIST $9.96
- ACLX N/A
- Revenue Growth
- VIST 22.63
- ACLX 230.33
- 52 Week Low
- VIST $30.46
- ACLX $47.88
- 52 Week High
- VIST $61.67
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- VIST 44.51
- ACLX 44.93
- Support Level
- VIST $51.75
- ACLX $63.38
- Resistance Level
- VIST $54.17
- ACLX $70.24
- Average True Range (ATR)
- VIST 2.20
- ACLX 2.95
- MACD
- VIST -0.51
- ACLX 0.74
- Stochastic Oscillator
- VIST 23.55
- ACLX 70.21
About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.